Ramit Mahajan
Overview
Explore the profile of Ramit Mahajan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kakkar C, Bonaffini P, Singh A, Narang V, Mahajan R, Verma S, et al.
Abdom Radiol (NY)
. 2025 Feb;
PMID: 39899083
Magnetic resonance enterography (MRE) has become an essential imaging modality for evaluating small bowel disorders, particularly Crohn's disease (CD), due to its superior soft-tissue contrast, multiplanar capabilities, and lack of...
2.
Singh A, Bhardwaj A, Sharma R, Kahlon B, Dhaliwal A, Singh D, et al.
Intest Res
. 2024 Nov;
PMID: 39523709
Background/aims: Accurate assessment of disease activity is crucial for effective management and treatment of ulcerative colitis (UC). This study evaluated the correlation between clinical, endoscopic, and histologic measures of disease...
3.
Verma P, Goyal S, Tyagi R, Ghuman M, Mahajan R, Selhi A, et al.
J Cytol
. 2024 May;
41(2):123-130.
PMID: 38779600
Introduction: The Papanicolaou Society of Cytopathology System for reporting Pancreaticobiliary Cytology (PSCPC) is a reliable method to classify pancreatic fine needle aspiration cytology (FNAC) smears. However, it is not without...
4.
Singh A, Mahajan R, Midha V, Kaur K, Singh D, Kaur R, et al.
Dig Dis Sci
. 2024 Feb;
69(4):1389-1402.
PMID: 38358458
Background: Ulcerative proctitis (UP), though associated with high symptom burden and poor quality of life, is excluded from most of the randomized controlled trials in UC, including the OCTAVE trials....
5.
Singh A, Bhardwaj A, Tripathi A, Ranjan M, Singh D, Sachdeva A, et al.
Dig Dis Sci
. 2024 Jan;
69(3):775-790.
PMID: 38282185
Background: Patients with Inflammatory bowel disease (IBD) are susceptible to psychiatric co-morbidities. We aimed to ascertain the burden of anxiety, depression, and perceived stress in patients with IBD from north...
6.
Singh A, Goyal M, Midha V, Mahajan R, Kaur K, Gupta Y, et al.
Am J Gastroenterol
. 2023 Dec;
119(7):1365-1372.
PMID: 38131615
Introduction: Intravenous corticosteroids are the mainstay of treatment of patients hospitalized with acute severe ulcerative colitis (ASUC). However, 30%-40% of the patients are refractory to corticosteroids. We investigated whether addition...
7.
Garg A, Sohal A, Kalra S, Singh C, Singh I, Grewal J, et al.
Cureus
. 2023 Nov;
15(10):e47536.
PMID: 38022053
Background and objective More than half of the population suffering from inflammatory bowel disease (IBD) use the internet as a primary source of information on their condition. X (formerly Twitter)...
8.
Dharni K, Singh A, Sharma S, Midha V, Kaur K, Mahajan R, et al.
Indian J Gastroenterol
. 2023 Oct;
43(1):188-198.
PMID: 37783933
Background: The global burden of inflammatory bowel disease (IBD) is reportedly increasing. Methodologies and datasets are routinely updated, allowing for more accurate estimates to guide healthcare policy. Methods: The Global...
9.
Dutta A, Jain A, Jearth V, Mahajan R, Panigrahi M, Sharma V, et al.
Indian J Gastroenterol
. 2023 Sep;
42(5):601-628.
PMID: 37698821
Proton pump inhibitors (PPIs) have been available for over three decades and are among the most commonly prescribed medications. They are effective in treating a variety of gastric acid-related disorders....
10.
Singh A, Midha V, Kaur K, Mahajan R, Singh D, Kaur R, et al.
J Crohns Colitis
. 2023 Sep;
18(2):300-307.
PMID: 37656880
Background: Oral corticosteroids are first-line agents to induce remission in moderately active ulcerative colitis [UC], but are associated with adverse effects. We compared the efficacy and safety of tofacitinib and...